These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2031152)

  • 1. C5 does not play a major role in the immune response of mice to SRBC in vivo.
    van den Berg CW; van Horssen PJ; Hofhuis FM; Aerts PC; van Dijk H
    Scand J Immunol; 1991 May; 33(5):621-6. PubMed ID: 2031152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3- and T-cell-dependent adjuvant activity of in vivo formed immune complexes.
    Van den Berg CW; Hazenberg MA; Hofhuis FM; Van Rooyen SM; Van Dijk H
    Immunology; 1991 Jul; 73(3):264-70. PubMed ID: 1879875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice naturally tolerant to C5 have T cells that suppress the response to this antigen.
    Cairns L; Rosen FS; Borel Y
    Eur J Immunol; 1986 Oct; 16(10):1277-82. PubMed ID: 2945729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of C5/C5a in the efferent and elicitation phases of contact sensitivity.
    Tsuji RF; Kikuchi M; Askenase PW
    J Immunol; 1996 Jun; 156(12):4444-50. PubMed ID: 8648091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shock.
    Barton PA; Warren JS
    Infect Immun; 1993 Apr; 61(4):1474-81. PubMed ID: 8454352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on immunosuppression by cobra venom factor. III. On early responses to sheep erythrocytes in C5-deficient mice.
    Martinelli GP; Matsuda T; Waks HS; Osler AG
    J Immunol; 1978 Nov; 121(5):2052-5. PubMed ID: 712078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pulmonary response of C5 sufficient and deficient mice to Pseudomonas aeruginosa.
    Larsen GL; Mitchell BC; Harper TB; Henson PM
    Am Rev Respir Dis; 1982 Aug; 126(2):306-11. PubMed ID: 7103255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds.
    Cerquetti MC; Sordelli DO; Bellanti JA; Hooke AM
    Infect Immun; 1986 Jun; 52(3):853-7. PubMed ID: 3086235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for complement C5 in organism containment and granulomatous response during murine tuberculosis.
    Actor JK; Breij E; Wetsel RA; Hoffmann H; Hunter RL; Jagannath C
    Scand J Immunol; 2001 May; 53(5):464-74. PubMed ID: 11309154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage accumulation in primary and transplanted tumors growing in C5-deficient B10.D2/oSn mice.
    Evans R
    Int J Cancer; 1980 Aug; 26(2):227-9. PubMed ID: 7203715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative responses that implicate new roles for the C-system in neuronal and astrocytic functions.
    Pasinetti GM; Tocco G; Sakhi S; Musleh WD; DeSimoni MG; Mascarucci P; Schreiber S; Baudry M; Finch CE
    Neurobiol Dis; 1996; 3(3):197-204. PubMed ID: 8980020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of IgG and complement component C5 in the initial course of experimental cryptococcosis.
    Dromer F; Perronne C; Barge J; Vilde JL; Yeni P
    Clin Exp Immunol; 1989 Dec; 78(3):412-7. PubMed ID: 2612053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis.
    Wang Y; Kristan J; Hao L; Lenkoski CS; Shen Y; Matis LA
    J Immunol; 2000 Apr; 164(8):4340-7. PubMed ID: 10754334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A natural model of immunologic tolerance. Tolerance to murine C5 is mediated by T cells, and antigen is required to maintain unresponsiveness.
    Harris DE; Cairns L; Rosen FS; Borel Y
    J Exp Med; 1982 Aug; 156(2):567-84. PubMed ID: 6808076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory properties of Nocardia lysozyme digest (NLD) in complement normal and C5-deficient mice.
    Georgieva P; Ivanovska N; Barot-Ciorbaru R
    Vaccine; 1998 Jul; 16(11-12):1237-42. PubMed ID: 9682384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5'-exon.
    Wetsel RA; Fleischer DT; Haviland DL
    J Biol Chem; 1990 Feb; 265(5):2435-40. PubMed ID: 2303408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal physiological parameters of two congenic mice strains: C5 deficient C57BL/6 and C5 sufficient A/J.
    Bavia L; de Castro ÍA; Massironi SM; Isaac L
    Immunol Lett; 2014; 159(1-2):47-54. PubMed ID: 24607390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe and prolonged inflammatory response to localized cowpox virus infection in footpads of C5-deficient mice: investigation of the role of host complement in poxvirus pathogenesis.
    Miller CG; Justus DE; Jayaraman S; Kotwal GJ
    Cell Immunol; 1995 May; 162(2):326-32. PubMed ID: 7743560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schistosoma mansoni: development of primary infections in mice genetically deficient or intact in the fifth component of complement.
    Ruppel A; Rother U; Diesfeld HJ
    Parasitology; 1982 Oct; 85 (Pt 2)():315-23. PubMed ID: 7145473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate and acquired immune responses against Candida albicans in congenic B10.D2 mice with deficiency of the C5 complement component.
    Lyon FL; Hector RF; Domer JE
    J Med Vet Mycol; 1986 Oct; 24(5):359-67. PubMed ID: 3537260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.